Nyxoah (Belgium) Today
| NYXH Stock | EUR 7.78 0.08 1.04% |
Performance0 of 100
| Odds Of DistressLess than 22
|
Nyxoah is selling at 7.78 as of the 15th of December 2024; that is 1.04 percent increase since the beginning of the trading day. The stock's lowest day price was 7.6. Nyxoah has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 15th of November 2024 and ending today, the 15th of December 2024. Click here to learn more.
Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium. NYXOAH is traded on Brussels Stock Exchange in Belgium.. The company has 25.85 M outstanding shares. More on Nyxoah
Moving together with Nyxoah Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nyxoah Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nyxoah's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nyxoah or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Nyxoah (NYXH) is traded on Euronext Brussels in Belgium and employs 105 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 123.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nyxoah's market, we take the total number of its shares issued and multiply it by Nyxoah's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nyxoah operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 25.85 M outstanding shares.
Nyxoah has accumulated about 86.21 M in cash with (25.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.9.
Check Nyxoah Probability Of Bankruptcy
Ownership AllocationNyxoah maintains a total of 25.85 Million outstanding shares. Nyxoah holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nyxoah Ownership Details
Nyxoah Risk Profiles
Although Nyxoah's alpha and beta are two of the key measurements used to evaluate Nyxoah's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.67 | |||
| Semi Deviation | 2.11 | |||
| Standard Deviation | 2.31 | |||
| Variance | 5.34 |
Nyxoah Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nyxoah without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Nyxoah Corporate Management
Elected by the shareholders, the Nyxoah's board of directors comprises two types of representatives: Nyxoah inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nyxoah. The board's role is to monitor Nyxoah's management team and ensure that shareholders' interests are well served. Nyxoah's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nyxoah's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeremy Feffer | VP Communication | Profile | |
| Dorit Nahari | VP Operations | Profile | |
| Olivier Taelman | CEO Director | Profile | |
| An Moonen | G Counsel | Profile | |
| Robert MBA | CoFounder Chairman | Profile | |
| Loic Moreau | Chief Officer | Profile | |
| Bruno Onkelinx | Chief Officer | Profile |
Additional Tools for Nyxoah Stock Analysis
When running Nyxoah's price analysis, check to measure Nyxoah's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nyxoah is operating at the current time. Most of Nyxoah's value examination focuses on studying past and present price action to predict the probability of Nyxoah's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nyxoah's price. Additionally, you may evaluate how the addition of Nyxoah to your portfolios can decrease your overall portfolio volatility.